Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.
about
Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocolsCurrent applications and different approaches for microbial l-asparaginase productionEngineering of Helicobacter pylori L-asparaginase: characterization of two functionally distinct groups of mutantsThe feature of TRGV and TRDV repertoire distribution and clonality in patients with immune thrombocytopenic purpura.Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP.Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines.Asparagine synthetase: regulation by cell stress and involvement in tumor biologyAsparagine synthetase chemotherapy.Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.Changes of T-lymphocyte subpopulation and differential expression pattern of the T-bet and GATA-3 genes in diffuse large B-cell lymphoma patients after chemotherapyMesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01.Possibilities for tailored and targeted therapy in paediatric acute myeloid leukaemia.Recombinant L-Asparaginase from Zymomonas mobilis: A Potential New Antileukemic Agent Produced in Escherichia coli.The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia.PEG-asparaginase.Adipocytes cause leukemia cell resistance to L-asparaginase via release of glutamine.Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinomaThe evolution of malignant and reactive γδ + T cell clones in a relapse T-ALL case after allogeneic stem cell transplantation.A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginaseA prospective study on drug monitoring of PEGasparaginase and Erwinia asparaginase and asparaginase antibodies in pediatric acute lymphoblastic leukemia.Cancer cell metabolism: one hallmark, many faces.Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia.Genome-wide loss-of-function genetic screening identifies opioid receptor μ1 as a key regulator of L-asparaginase resistance in pediatric acute lymphoblastic leukemiaAutophagy is required for cell survival under L-asparaginase-induced metabolic stress in acute lymphoblastic leukemia cells.A clinically attainable dose of L-asparaginase targets glutamine addiction in lymphoid cell lines.Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell linesDifferentiating hypersensitivity versus infusion-related reactions in pediatric patients receiving intravenous asparaginase therapy for acute lymphoblastic leukemia.Understanding the Intersections between Metabolism and Cancer Biology.Asparaginase pharmacology: challenges still to be faced.Downregulation of phosphatase of regenerating liver-3 is involved in the inhibition of proliferation and apoptosis induced by emodin in the SGC-7901 human gastric carcinoma cell line.Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukaemia.Selective apoptosis of natural killer-cell tumours by l-asparaginase.Epigenetic changes in the repression and induction of asparagine synthetase in human leukemic cell lines.The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia.In vitro efficacy of l-asparaginase in childhood acute myeloid leukaemia.Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells.Upregulation of asparagine synthetase and cell cycle arrest in t(12;21)-positive ALL.Gene expression of Hsp70, Hsp90 and Hsp110 families in normal palate and cleft palate during mouse embryogenesis.
P2860
Q24685883-CAC61EB0-0499-42AE-8438-8EB862424FD1Q28072068-35903ECA-B687-4796-8D4B-14FFD554CD34Q28543369-ABDE9607-ADD2-4467-914A-0FDBC339FB41Q33385552-88C49D16-1D05-4006-8F84-8E37F755E75DQ33431511-202E3DD9-4948-444B-9420-BB7C19021ECAQ34011217-2DE7D1E1-A474-46D6-A4BD-84A24892B52CQ34327474-56F23613-BC28-42A0-B06C-93F36C063EC9Q34535185-5FC5FBAD-F495-4343-8E4C-8BEB959492A0Q34894425-047BA071-BD4A-452A-A219-D4D905E51D30Q34989475-CEDBE0E8-5561-4EE1-8224-5CB7541C1BB3Q35108406-5B5E663D-D6A9-444C-A423-07BBFE0F2213Q35677647-3BC59A0E-D955-4B68-B61B-CB7D4C2375B6Q35849716-44941EFB-9F8A-4F29-9F49-CD9D76D0FB77Q35921471-9502D665-C903-44C2-9682-7BD794F49BBDQ36038158-B5308658-1F61-42F8-8D5E-0059E4EF832CQ36513656-8EFC9B89-BED4-4BCD-875B-03FD9218DBC0Q36909298-2E7DD8C8-3AE2-4768-A1DF-37D62907EC77Q36933370-2EC56437-F792-4AF0-84EC-7A73B97A47F9Q37003403-8379212B-700C-42E5-9D0A-172C35C64B58Q37028734-A37C7E0A-2158-489A-A358-AB7C3FC35F79Q37241386-ECAC3BD2-6CBE-49D8-8459-52E19642EA0EQ37670065-8634D169-1ABA-4276-BFAE-7042EE06EE25Q38046274-45811518-163D-4E32-BAA9-2CEEDAE51621Q38248280-11C8E750-D1FC-42C7-99C6-AC00E9942207Q38709044-4C4AA364-5F41-4528-B8F6-C1824A0A942DQ38739170-374BC761-0518-43F9-84F3-F085A6BE70E6Q38838632-E4F48489-AF6B-442C-9BD7-66C61987DFDBQ38915906-EA36AF0D-159F-473C-96DF-380DE7F342C6Q38933372-8A9E9025-5AF4-4B3F-B35C-D3A501547909Q39130440-6D4E9FF6-7068-4498-BB24-509AD750D61DQ39135887-8F08894C-8671-4949-9ABA-39CCF670A8ADQ39280610-7C6795E3-6D31-45C8-9A21-327906A1B8A2Q40314849-C9515E1A-667E-4698-A20E-51B5A666BBC5Q40374756-4B87F6ED-6D0F-45C6-9A56-2A19F396CE03Q40464790-9761B400-4E61-4A8D-BC05-F7C924BF6870Q42741956-481E3443-0BD7-4969-A035-39F65DBB9582Q44665397-759229B9-BC45-41E1-B3B2-10550208B3B0Q44729078-F0643057-CB3E-4203-AB1B-6F06C0C85B00Q45138884-C9C318A3-8A00-4DD1-8B87-F3E0F143E270Q45286206-F4332F45-CBB4-4B17-AB80-330FFD41A042
P2860
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Sensitivity to L-asparaginase ...... of asparagine synthetase in t
@nl
Sensitivity to L-asparaginase ...... se in t(12;21)+ pediatric ALL.
@en
type
label
Sensitivity to L-asparaginase ...... of asparagine synthetase in t
@nl
Sensitivity to L-asparaginase ...... se in t(12;21)+ pediatric ALL.
@en
prefLabel
Sensitivity to L-asparaginase ...... of asparagine synthetase in t
@nl
Sensitivity to L-asparaginase ...... se in t(12;21)+ pediatric ALL.
@en
P2093
P1433
P1476
Sensitivity to L-asparaginase ...... se in t(12;21)+ pediatric ALL.
@en
P2093
Elisabeth R van Wering
Gritta E Janka-Schaub
H Berna Beverloo
Jules P P Meijerink
Rolinda L Stigter
Rosalyn Slater
Wendy A G Stams
P304
P356
10.1182/BLOOD-2002-08-2446
P407
P577
2002-11-14T00:00:00Z